Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2012, Article ID 179849, 8 pages
http://dx.doi.org/10.1155/2012/179849
Clinical Study

Simple Cystatin C Formula for Estimation of Glomerular Filtration Rate in Overweight Patients with Diabetes Mellitus Type 2 and Chronic Kidney Disease

1Department of Nephrology, Clinic of Internal Medicine, University Medical Center Maribor, 2000 Maribor, Slovenia
2Department of Endocrinology and Diabetology, Clinic of Internal Medicine, University Medical Center Maribor, 2000 Maribor, Slovenia
3Department of Clinical Chemistry, Clinic of Internal Medicine, University Medical Center Maribor, 2000 Maribor, Slovenia
4Department of Nuclear Medicine, Clinic of Internal Medicine, University Medical Center Maribor, 2000 Maribor, Slovenia

Received 18 April 2012; Revised 28 June 2012; Accepted 12 July 2012

Academic Editor: Bernard Portha

Copyright © 2012 Sebastjan Bevc et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. L. Myers, W. G. Miller, J. Coresh et al., “Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program,” Clinical Chemistry, vol. 52, no. 1, pp. 5–18, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. A. S. Go, G. M. Chertow, D. Fan, C. E. McCulloch, and C. Y. Hsu, “Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization,” The New England Journal of Medicine, vol. 351, no. 13, pp. 1296–1305, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. L. A. Stevens, J. Coresh, T. Greene, and A. S. Levey, “Assessing kidney function—measured and estimated glomerular filtration rate,” The New England Journal of Medicine, vol. 354, no. 23, pp. 2473–2483, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. A. S. Levey, R. L. Berg, J. J. Gassman, P. M. Hall, and W. G. Walker, “Creatinine filtration, secretion and excretion during progressive renal disease,” Kidney International, vol. 36, supplement 27, pp. S73–S80, 1989. View at Google Scholar · View at Scopus
  5. “National Kidney Foundation: K/DOQI Clinical practice guideline to define chronic kidney disease: evaluation, classification and stratification,” American Journal of Kidney Diseases, vol. 39, supplement 1, pp. S1–S266, 2002.
  6. M. Froissart, J. Rossert, C. Jacquot, M. Paillard, and P. Houillier, “Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function,” Journal of the American Society of Nephrology, vol. 16, no. 3, pp. 763–773, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. American Diabetes Association Position Statement, “Standard of Medical Care in Diabetes,” Diabetes Care, vol. 32, pp. 33–34, 2009. View at Google Scholar
  8. E. D. Poggio, X. Wang, T. Greene, F. Van Lente, and P. M. Hall, “Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease,” Journal of the American Society of Nephrology, vol. 16, no. 2, pp. 459–466, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. A. S. Levey, L. A. Stevens, C. H. Schmid et al., “A new equation to estimate glomerular filtration rate; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration),” Annals of Internal Medicine, vol. 150, no. 9, pp. 604–612, 2009. View at Google Scholar
  10. E. Randers and E. J. Erlandsen, “Serum cystatin C as an endogenous marker of the renal function—a review,” Clinical Chemistry and Laboratory Medicine, vol. 37, no. 4, pp. 389–395, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Coll, A. Botey, L. Alvarez et al., “Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment,” American Journal of Kidney Diseases, vol. 36, no. 1, pp. 29–34, 2000. View at Google Scholar · View at Scopus
  12. V. R. Dharnidharka, C. Kwon, and G. Stevens, “Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis,” American Journal of Kidney Diseases, vol. 40, no. 2, pp. 221–226, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Willems, F. Wolff, F. Mekahli, and C. Gillet, “Cystatin C for early detection of renal impairment in diabetes,” Clinical Biochemistry, vol. 42, no. 1-2, pp. 108–110, 2009. View at Google Scholar
  14. R. B. Dhia, I. Hellara, O. Harzallah et al., “Evaluation of the renal function in type 2 diabetes: clearance calculation or cystatin C?” Analyses de Biologie Clinique, vol. 70, no. 3, pp. 287–294, 2012. View at Google Scholar
  15. R. Hojs, S. Bevc, B. Antolinc, M. Gorenjak, and L. Puklavec, “Serum cystatin C as an endogenous marker of renal function in the elderly,” International Journal of Clinical Pharmacology Research, vol. 24, no. 2-3, pp. 49–54, 2004. View at Google Scholar · View at Scopus
  16. R. Hojs, S. Bevc, R. Ekart, M. Gorenjak, and L. Puklavec, “Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function,” Nephrology Dialysis Transplantation, vol. 21, no. 7, pp. 1855–1862, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Grubb, U. Nyman, J. Björk et al., “Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children,” Clinical Chemistry, vol. 51, no. 8, pp. 1420–1431, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. F. J. Hoek, F. A. W. Kemperman, and R. T. Krediet, “A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate,” Nephrology Dialysis Transplantation, vol. 18, no. 10, pp. 2024–2031, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Larsson, J. Malm, A. Grubb, and L. O. Hansson, “Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 64, no. 1, pp. 25–30, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. R. J. MacIsaac, C. Tsalamandris, M. C. Thomas et al., “Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods,” Diabetologia, vol. 49, no. 7, pp. 1686–1689, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. A. D. Rule, E. J. Bergstralh, J. M. Slezak, J. Bergert, and T. S. Larson, “Glomerular filtration rate estimated by cystatin C among different clinical presentations,” Kidney International, vol. 69, no. 2, pp. 399–405, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Hojs, S. Bevc, R. Ekart, M. Gorenjak, and L. Puklavec, “Serum crystatin C-based equation compared to serum creatinine-based equations for estimation of glomerular filtration rate in patient with chronic kidney disease,” Clinical Nephrology, vol. 70, no. 1, pp. 10–17, 2008. View at Google Scholar · View at Scopus
  23. M. Tidman, P. Sjöström, and I. Jones, “A comparison of GFR estimating formulae based upon s-cystatin C and s-creatinine and a combination of the two,” Nephrology Dialysis Transplantation, vol. 23, no. 1, pp. 154–160, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. R. A. Chudleigh, R. L. Ollerton, G. Dunseath et al., “Use of cystatin C-based estimations of glomerular filtration rate in patients with type 2 diabetes,” Diabetologia, vol. 52, no. 7, pp. 1274–1278, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. C. Ma, L. Zuo, J. H. Chen et al., “Improved GFR estimation by combined creatinine and cystatin C measurements,” Kidney International, vol. 72, no. 12, pp. 1535–1542, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. L. A. Stevens, J. Coresh, C. H. Schmid et al., “Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD,” American Journal of Kidney Diseases, vol. 51, no. 3, pp. 395–406, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. R. A. Chudleigh, G. Dunseath, R. Peter et al., “Influence of body weight on the performance of glomerular filtration rate estimators in subjects with type 2 diabetes,” Diabetes Care, vol. 31, no. 1, pp. 47–49, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. F. X. Pi-Sunyer, “Weight loss and mortality in type 2 diabetes,” Diabetes Care, vol. 23, no. 10, pp. 1451–1452, 2000. View at Google Scholar · View at Scopus
  29. B. C. Mazzachi, M. J. Peake, and V. Ehrhardt, “Reference range and method comparison studies for enzymatic and Jaffe creatinine assays in plasma and serum and early morning urine,” Clinical Laboratory, vol. 46, no. 1-2, pp. 53–55, 2000. View at Google Scholar · View at Scopus
  30. M. D. Blaufox, M. Aurell, B. Bubeck et al., “Report of the radionuclides in nephrourology committee on renal clearance,” Journal of Nuclear Medicine, vol. 37, no. 11, pp. 1883–1890, 1996. View at Google Scholar · View at Scopus
  31. B. A. Perkins, R. G. Nelson, B. E. P. Ostrander et al., “Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study,” Journal of the American Society of Nephrology, vol. 16, no. 5, pp. 1404–1412, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. J. M. Bland and D. G. Altman, “Statistical methods for assessing agreement between two methods of clinical measurement,” The Lancet, vol. 1, no. 8476, pp. 307–310, 1986. View at Google Scholar · View at Scopus
  33. R. Hojs, S. Bevc, R. Ekart, M. Gorenjak, and L. Puklavec, “Serum cystatin C-based formulas for prediction of glomerular filtration rate in patients with chronic kidney disease,” Nephron—Clinical Practice, vol. 114, no. 2, pp. c118–c126, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. L. A. Stevens, J. Coresh, H. I. Feldman et al., “Evaluation of the modification of diet in renal disease study equation in a large diverse population,” Journal of the American Society of Nephrology, vol. 18, no. 10, pp. 2749–2757, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. M. A. van de Ree, J. C. M. van der Vijver, and W. Geerlings, “The value of the Cockcroft formula in obese diabetic patients,” The Netherlands Journal of Medicine, vol. 50, no. 5, pp. 17–17(1), 1997. View at Google Scholar
  36. M. A. van de Ree, G. Christiaan, M. V. Huisman, J. C. M. van der Vijver, and A. E. Meinders, “Monitoring renal function in obese patients with type 2 diabetes mellitus in daily practice,” Diabetes, Nutrition and Metabolism—Clinical and Experimental, vol. 14, no. 2, pp. 66–70, 2001. View at Google Scholar · View at Scopus
  37. V. Rigalleau, M. C. Beauvieux, F. Le Moigne et al., “Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate in diabetes,” Diabetes and Metabolism, vol. 34, no. 5, pp. 482–489, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. V. Rigalleau, C. Lasseur, C. Perlemoine et al., “A simplified Cockcroft-Gault formula to improve the prediction of the glomerular filtration rate in diabetic patients,” Diabetes and Metabolism, vol. 32, no. 1, pp. 56–62, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. L. A. Inker, J. Eckfeldt, A. S. Levey et al., “Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values,” American Journal of Kidney Diseases, vol. 58, pp. 682–684, 2011. View at Google Scholar
  40. S. Blirup-Jensen, A. Grubb, V. Lindström, C. Schmidt, and H. Althaus, “Standardization of Cystatin C: development of primary and secondary reference preparations,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 68, no. 241, pp. 67–70, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Grubb, S. Blirup-Jensen, V. Lindström, C. Schmidt, H. Althaus, and I. Zegers, “First certified reference material for Cystatin C in human serum ERM-DA471/IFCC,” Clinical Chemistry and Laboratory Medicine, vol. 48, no. 11, pp. 1619–1621, 2010. View at Publisher · View at Google Scholar · View at Scopus